These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11693845)

  • 1. Mouthpiece diameter affects deposition efficiency in cast models of the human oral airways.
    Lin TC; Breysse PN; Laube BL; Swift DL
    J Aerosol Med; 2001; 14(3):335-41. PubMed ID: 11693845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurements of electrodynamic effects on the deposition of MDI and DPI aerosols in a replica cast of human oral-pharyngeal-laryngeal airways.
    Ali M; Mazumder MK; Martonen TB
    J Aerosol Med Pulm Drug Deliv; 2009 Mar; 22(1):35-44. PubMed ID: 18800879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balloon-based in vitro MDI aerosol deposition experiments on the effects of mouthpiece diameter.
    Fadl A; Wang J; Yang P; Zhang Z; Cheng YS
    Inhal Toxicol; 2007 May; 19(6-7):505-15. PubMed ID: 17497529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis and design of a spray aerosol inhaler. Part 2: improvements in mouthpiece performance.
    Hindle M; Longest PW
    J Aerosol Med Pulm Drug Deliv; 2013 Oct; 26(5):237-47. PubMed ID: 23098326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metered-dose inhaler efficiency enhancement: a case study and novel design.
    Fadl A; Wang J; Zhang Z
    Inhal Toxicol; 2010 Jun; 22(7):601-9. PubMed ID: 20387999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oropharyngeal deposition of 3.5 microns particles inhaled through an elongated mouthpiece.
    Svartengren K; Anderson M; Svartengren M; Philipson K; Camner P
    Eur Respir J; 1996 Jul; 9(7):1556-9. PubMed ID: 8836672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro monodisperse aerosol deposition in a mouth and throat with six different inhalation devices.
    DeHaan WH; Finlay WH
    J Aerosol Med; 2001; 14(3):361-7. PubMed ID: 11693848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of gender and device mouthpiece shape on bolus insulin aerosol delivery using the AERx pulmonary delivery system.
    Boyd B; Noymer P; Liu K; Okikawa J; Hasegawa D; Warren S; Taylor G; Ferguson E; Schuster J; Farr S; Gonda I
    Pharm Res; 2004 Oct; 21(10):1776-82. PubMed ID: 15553222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internal mouthpiece designs as a future perspective for enhanced aerosol deposition. Comparative results for aerosol chemotherapy and aerosol antibiotics.
    Zarogoulidis P; Petridis D; Ritzoulis C; Darwiche K; Kioumis I; Porpodis K; Spyratos D; Hohenforst-Schmidt W; Yarmus L; Huang H; Li Q; Freitag L; Zarogoulidis K
    Int J Pharm; 2013 Nov; 456(2):325-31. PubMed ID: 24035789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting the deposition of inhaled porous drug particles.
    Musante CJ; Schroeter JD; Rosati JA; Crowder TM; Hickey AJ; Martonen TB
    J Pharm Sci; 2002 Jul; 91(7):1590-600. PubMed ID: 12115821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tubing deposition, breathing pattern, and temperature on aerosol mass distribution measured by cascade impactor.
    Gurses BK; Smaldone GC
    J Aerosol Med; 2003; 16(4):387-94. PubMed ID: 14977429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling of aerosol deposition with interface devices.
    Finlay WH; Martin AR
    J Aerosol Med; 2007; 20 Suppl 1():S19-26; discussion S27-8. PubMed ID: 17411402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particle characteristics and lung deposition patterns in a human airway replica of a dry powder formulation of polylactic acid produced using supercritical fluid technology.
    Cheng YS; Yazzie D; Gao J; Muggli D; Etter J; Rosenthal GJ
    J Aerosol Med; 2003; 16(1):65-73. PubMed ID: 12737686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Particle size selection device for use with the Turbohaler.
    Everard ML; Devadason SG; Le Souef PN
    Thorax; 1996 May; 51(5):537-9. PubMed ID: 8711685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis and design of a spray aerosol inhaler. Part 1: effects of dilution air inlets and flow paths.
    Longest PW; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2009 Sep; 22(3):271-83. PubMed ID: 19466904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Special problems in aerosol delivery: neonatal and pediatric considerations.
    Cole CH
    Respir Care; 2000 Jun; 45(6):646-51. PubMed ID: 10894457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 1: Grid structure and mouthpiece length.
    Coates MS; Fletcher DF; Chan HK; Raper JA
    J Pharm Sci; 2004 Nov; 93(11):2863-76. PubMed ID: 15389665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical relevance of dry powder inhaler performance for drug delivery.
    Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
    Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deposition of Particles in Human Mouth-Throat Replicas and a USP Induction Port.
    Cheng YS; Zhou Y; Su WC
    J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):147-55. PubMed ID: 25137223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pressurized metered dose inhalers and add-on devices.
    Terzano C
    Pulm Pharmacol Ther; 2001; 14(5):351-66. PubMed ID: 11603949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.